A detailed history of Metis Global Partners, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Metis Global Partners, LLC holds 17,292 shares of BAX stock, worth $575,996. This represents 0.02% of its overall portfolio holdings.

Number of Shares
17,292
Previous 16,863 2.54%
Holding current value
$575,996
Previous $564,000 16.31%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$32.85 - $40.26 $14,092 - $17,271
429 Added 2.54%
17,292 $656,000
Q2 2024

Aug 06, 2024

BUY
$32.87 - $43.55 $1,117 - $1,480
34 Added 0.2%
16,863 $564,000
Q1 2024

May 06, 2024

SELL
$37.88 - $43.77 $7,765 - $8,972
-205 Reduced 1.2%
16,829 $719,000
Q4 2023

Feb 06, 2024

SELL
$31.71 - $38.95 $57,680 - $70,850
-1,819 Reduced 9.65%
17,034 $658,000
Q3 2023

Nov 07, 2023

BUY
$37.32 - $49.29 $122,484 - $161,769
3,282 Added 21.08%
18,853 $711,000
Q2 2023

Aug 07, 2023

SELL
$39.98 - $47.68 $211,614 - $252,370
-5,293 Reduced 25.37%
15,571 $709,000
Q1 2023

May 08, 2023

BUY
$37.58 - $52.57 $249,418 - $348,907
6,637 Added 46.65%
20,864 $846,000
Q4 2022

Feb 07, 2023

BUY
$49.7 - $57.71 $331,996 - $385,502
6,680 Added 88.51%
14,227 $725,000
Q3 2022

Nov 08, 2022

SELL
$53.86 - $66.8 $1,508 - $1,870
-28 Reduced 0.37%
7,547 $406,000
Q2 2022

Aug 08, 2022

SELL
$63.83 - $80.0 $21,893 - $27,440
-343 Reduced 4.33%
7,575 $486,000
Q1 2022

May 03, 2022

BUY
$76.85 - $89.45 $273,278 - $318,084
3,556 Added 81.52%
7,918 $613,000
Q4 2021

Feb 11, 2022

BUY
$74.57 - $87.19 $325,274 - $380,322
4,362 New
4,362 $374,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.8B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Metis Global Partners, LLC Portfolio

Follow Metis Global Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metis Global Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Metis Global Partners, LLC with notifications on news.